ECRIN (European Clinical Research Infrastructure Network)

ECRIN is there to support requests for information from investigators and sponsors in our member countries. 💬 The acquisition of general information and support in the planning of a clinical study is of utmost importance in understanding the regulatory landscape, identifying funding opportunities and correctly defining the scope, roles and responsibilities of the work to include in the funding application. This assistance ensures initial clinical research questions become an operational reality. 🌟 👉 Learn about this and our full-service offer in our updated clinical trials brochure: https://lnkd.in/gfWwcqby

If you are involved in academic multinational trials in Europe as a sponsor, an investigational site, a CRO, a CTU, or involved in the development of national procedures/templates for harmonisation of CTA, we have developed this survey for you! Working within the ERA4Health Partnership, the ultimate goal is the development of a harmonised Clinical Trial Agreement (CTA) to facilitate the conduct of academic multinational clinical trials in Europe.   Your invaluable input will help us: • Collect information about the existing CTA templates/models across the EU • Get a broader understanding of the issues encountered by the academic sponsors of multinational clinical trials and other relevant actors when dealing and negotiating CTAs in the context of multinational clinical trials, • Identify the negotiable and non-negotiable national specificities (e.g. provisions mandatory by law) of CTAs • Find a shared understanding of how an EU CTA template should look like so that it can be used as a model in the context of academic multinational clinical trials   Interested in contributing to this work? Answer here: https://lnkd.in/e5pSZKX5 #ClinicalTrials, #CTA, #harmonisation CZECRIN, Infrastructure F-CRIN, KKS-Netzwerk e. V., HRB National Clinical Trials Office (NCTO), NorCRIN, PtCRIN Portuguese Clinical Research Infrastructure Network, SLOVACRIN, Spanish Clinical Research Network (SCReN), Swiss Clinical Trial Organisation, European Medicines Agency

The EJP-RD project has just come to an end. Learn about ECRIN’s role in this project and some of the exciting ways ECRIN supports the rare disease community. 🌈  Our Head of Capacity Projects and rare diseases expert, Marta del Álamo sheds some light on this subject in the dedicated annual report interview. 💡 👉 View the full interview today: https://lnkd.in/ezA5xyXR

ECRIN's Director General, Jacques Demotes sat down to discuss investigator initiated clinical trials in a special edition of the ERA4Health newsletter. He discusses what they are, funding opportunities, the advantages of ensuring that they can be carried out across borders and how ERA4Health is looking to support them. Take a minute and peruse the article ⬇

What does an ECRIN coordinating European Correspondent do? 🤔 We sat down with Dr. Linda Stöhr & Neshat Chareh, PhD, our German EuCos, to learn more about this role and how ECRIN supports the KKS-Netzwerk e. V. in Germany. 🤝    👉 Take a minute and read the interview to get the answers to these questions and more: https://lnkd.in/dPyq-n-f  

How does ECRIN help Sponsors and Investigators conduct multinational clinical studies? 👇 Throughout the whole process our staff and notably European Correspondents provide Expertise and Overarching support for the maturation and execution of investigator and sponsors’ ideas. 💡    They ensure a solid understanding of the different roles and responsibilities associated with the different steps and work to define a clear task distribution. 📝   👉 Learn about this and our full service offer in our updated clinical trials brochure: https://lnkd.in/gfWwcqby

🚨 Attention cancer researchers! We’re excited to announce free services through the canSERV open calls, available until August 28th 2024. ⏳ 🌟 One of the current call focuses on Innovative approaches to research and clinical trials for improved treatment outcomes, with 2 topics on the spotlight: - 𝐄𝐧𝐬𝐮𝐫𝐞 𝐨𝐩𝐭𝐢𝐦𝐚𝐥 𝐭𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭 𝐨𝐮𝐭𝐜𝐨𝐦𝐞𝐬: tailoring research for different age groups (e.g., paediatric and elderly patients) - 𝐃𝐞𝐬𝐢𝐠𝐧𝐢𝐧𝐠 𝐢𝐦𝐩𝐫𝐨𝐯𝐞𝐝 𝐜𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐭𝐫𝐢𝐚𝐥𝐬 𝐟𝐨𝐫 𝐝𝐢𝐯𝐞𝐫𝐬𝐞 𝐩𝐨𝐩𝐮𝐥𝐚𝐭𝐢𝐨𝐧𝐬: for broader patient representation from EU and matched control groups. In this call, ECRIN offers expert guidance for the design of complex multinational trials, and a secure GDPR-compliant data storage for your research through the crDSR (clinical research data sharing repository). 🤲 👉 Seize this opportunity and apply now: https://lnkd.in/dEW3dnrN ✉ Contact us to learn more about ECRIN services: https://ecrin.org/contact #OpenCall #ResearchOpportunities #CancerResearch 

The highlights of the past five years of the European Joint Programme on Rare Diseases (EJP RD) programme are included in a new article. 🌟 Titled "The European joint programme on rare diseases: building the rare diseases research ecosystem" this article published on the Rare Diseases and Orphan Drugs Journal delves into our collective achievements and ongoing efforts to foster a robust research environment for rare diseases. 🚀 Through collaborative projects, innovative research, and dedicated support for the rare disease community, we continue to make strides in understanding and addressing these unique health challenges. Read the full article here: https://lnkd.in/eHXJA_6g

Very exciting announcement from the ERA4Health Partnership: a new funding opportunity for Investigator Initiated Clinical Studies coming this fall. Stay tuned for details on the topic to be addressed.

Congratulations to the TTV-GUIDE TX trial team! Today they announced that they have closed recruitment for the trial.